Fifth Third Bancorp
KALV

Fifth Third Bancorp’s KalVista Pharmaceuticals KALV Stock Holding History

Fifth Third Bancorp’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-519
Closed -$10.4K – 4405
2026
Q1 		$10.4K Buy
+519
New +$8.37K ﹤0.01% 3693

Other funds holding KALV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fifth Third Bancorp's KALV Position: Q2 2026 in Review

Fifth Third Bancorp sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 519 shares — an estimated $10.4K sold.

Fifth Third Bancorp first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $10.4K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

  • Fifth Third Bancorp reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Fifth Third Bancorp sold 519 KalVista Pharmaceuticals shares in Q2 2026, an estimated $10.4K.
  • Fifth Third Bancorp first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Fifth Third Bancorp's KalVista Pharmaceuticals position peaked at $10.4K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.